Axis Invests €5M in Tucuvi Care for AI Healthtech Growth

Tucuvi Care, a Spanish innovator in conversational AI for clinical patient monitoring, has secured €5 million in a growth funding round led by Axis, the venture capital arm of ICO. This capital infusion, channeled through the Fond-ICO Crecimiento fund, is earmarked to accelerate Tucuvi's international market penetration and bolster its development of advanced AI solutions for the healthcare sector, particularly focusing on elder care.

The investment underscores Axis's strategy to support technology firms with significant economic and social impact, especially within critical areas like healthcare and senior living. Tucuvi's platform, featuring its AI voice agent 'LOLA®', is designed to automate and scale clinical processes by engaging patients in conversations, identifying critical health events, and coordinating follow-up actions with medical teams. The company's CE Class IIb certification highlights its adherence to stringent medical device regulations.

With its technology already deployed across more than 80 healthcare organizations and partnerships with five major global pharmaceutical companies, Tucuvi is positioned to expand its reach. This funding will enable the company to solidify its leadership in regulated AI for healthcare, enhance its existing client relationships, and forge new strategic alliances with hospitals, health systems, and pharmaceutical firms. The international expansion is further supported by a regulatory environment increasingly favoring AI-driven interoperability and automation in healthcare systems.

The digital health market, particularly AI-powered solutions for patient monitoring and chronic disease management, is experiencing robust growth. Global spending on AI in healthcare is projected to reach tens of billions of dollars in the coming years, driven by an aging population and the increasing prevalence of chronic conditions requiring continuous oversight. Tucuvi's focus on conversational AI addresses a key need for scalable, efficient patient engagement solutions in this expanding market.

This funding round follows previous investments from notable venture capital firms including Cathay Innovation, Leadwind, Seaya, Frontline, and Shilling, demonstrating strong market confidence in Tucuvi's technology and business model. The addition of Fond-ICO Crecimiento as a key investor is expected to provide significant leverage for Tucuvi's next phase of growth and innovation.

Axis's investment in Tucuvi aligns with broader trends in the venture capital space, where investors are increasingly targeting healthtech companies that leverage AI to improve patient outcomes and operational efficiency within healthcare systems. The ability of Tucuvi's platform to augment existing healthcare capacity and improve the quality of care, especially for an aging demographic, presents a compelling value proposition.